Search results for: 'ecu test'

03 Jan 2018  |  North America  |  Market Outlook

Global Healthcare Industry Outlook, 2018

Value-based Care Will Continue to Drive Growth Opportunities for Emerging Technologies as They Move Out form Pilot Testing into Production Environments

Infographics

×

Key Issues Addressed Key Benefits

In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare industry in 2018. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

Advances in sensor technology that enhance navigation and object detection, advanced braking systems, image processing algorithms, and machine vision have created opportunities for automotive manufacturers to explore a wide range of automotive electronics solutions. Miniaturization of electronic components, product convergence, and smart device ado...

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are ...

10 Mar 2015  |  North America  |  Market Research

The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

Infographics

×

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and ...

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

This research service analyzes the market for reference laboratories within the United States. The United States market was divided into the routine testing, esoteric testing, clinical trials testing, and anatomic pathology and cytology market segments.

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...